Why In-Use Testing Matters
Standard shelf-life stability testing evaluates an unopened, sealed product under its intended storage conditions, but a multi-dose product is opened repeatedly over an in-use period following first opening, exposing it to conditions and handling that a sealed-container shelf-life study does not directly address, including repeated container opening, potential microbial contamination from patient handling, and, for certain products, dilution or reconstitution before use. In-use stability testing directly addresses this genuinely distinct risk period, providing data specifically supporting the labeled in-use period during which the product remains suitable for continued use following first opening or preparation.
Study Design
In-use stability study design should replicate realistic patient or healthcare provider handling as closely as practical, including representative container opening frequency, storage conditions between uses, such as refrigeration for products requiring it, and, for products requiring reconstitution or dilution before administration, the actual reconstitution or dilution procedure and subsequent storage conditions the labeled instructions will direct patients or providers to follow. A study design using unrealistically gentle handling, less frequent container opening, or more ideal storage conditions than genuine real-world use would provide, risks establishing an in-use period not actually achievable under realistic conditions patients will genuinely encounter.
Simulated Use Conditions
Simulated use conditions should specifically address the microbiological risk introduced by repeated container opening, evaluating both chemical and physical stability alongside microbial quality throughout the proposed in-use period, connecting directly to the preservative efficacy and antimicrobial effectiveness testing discussed elsewhere in this collection. For products requiring reconstitution, simulated use testing should evaluate stability starting from the actual moment of reconstitution using the labeled diluent and procedure, since reconstitution can itself introduce meaningful chemical or physical stability changes not present in the original unreconstituted product.
Setting In-Use Period
The proposed in-use period should be supported by data demonstrating the product remains within acceptable quality limits, chemical, physical, and microbiological, throughout that entire proposed period under the realistic simulated use conditions tested, with the labeled in-use period never exceeding what the actual supporting data genuinely demonstrates. Where in-use testing reveals the product cannot maintain acceptable quality for as long as might otherwise be desired commercially, the labeled in-use period must be set conservatively based on the actual demonstrated data, not extended beyond what genuine supporting evidence justifies regardless of commercial preference for a longer stated period.
Container and Delivery Device Considerations
In-use stability testing should use the product's actual intended commercial container and any associated delivery device, such as a dropper, applicator, or infusion set, since these components directly participate in realistic in-use handling and can themselves influence in-use stability, whether through moisture or oxygen ingress at a repeatedly opened closure or through drug adsorption onto delivery device materials during administration. Testing performed using a generic or non-representative container and delivery system provides limited genuine assurance regarding the actual commercial product's real in-use stability performance.
Products Requiring Refrigerated In-Use Storage
Products labeled for refrigerated storage during their in-use period present a particular practical testing consideration, since realistic patient use inevitably includes periods outside refrigerated storage, whether during actual administration or brief periods of imperfect adherence to labeled storage instructions, and in-use study design should incorporate a reasonable allowance for this realistic excursion behavior rather than assuming perfect, uninterrupted refrigeration throughout the entire labeled in-use period.
Regulatory Documentation Expectations
Regulatory submissions should present in-use stability data clearly connected to the specific labeled in-use period and instructions being proposed, with the underlying study design explicitly described to demonstrate its realistic representation of actual anticipated patient or healthcare provider use, giving reviewers direct, specific evidence supporting the proposed in-use claims rather than a generic assertion of adequate in-use stability unsupported by explicit study design detail.
Revisiting In-Use Data After Formulation or Packaging Changes
Any change to formulation, container, or delivery device should trigger reassessment of previously established in-use stability conclusions, since in-use stability depends directly on these specific product elements, and a change to any of them may invalidate the original in-use period conclusion even where standard sealed-container shelf-life stability remains entirely unaffected by the same change.
Leave your rating